Research News
The National Institutes of Health has awarded $1.6 million to researchers at SMHS for research on hormonal control of HIV latency.
It’s hard to recall a more important time for groundbreaking scientific research when it comes to the health and safety of the United States than in the past six months; by October the country had recorded more than 7 million cases of the novel coronavirus, and the global toll passed 1 million…
Four young researchers at the GW School of Medicine and Health Sciences were selected as fellows to the recently awarded five-year National Cancer Institute T32 Training Grant.
The retrospective study from a team at GW found that spironolactone may be safe to treat female pattern hair loss in breast cancer survivors.
Investigators at SMHS received a $1.2 million grant from Wellcome Trust to produce a controlled human hookworm infection model and establish a hookworm vaccine challenge model for two of the most advanced hookworm vaccine candidate antigens in endemic areas.
Timothy Harlan, MD, co-authored an article in The British Journal arguing for increased of "food is medicine" interventions in the health care system.
Alberto Bosque, PhD, MBA, assistant professor of microbiology, immunology, and tropical medicine, and his research team published in PLOS Pathogens finding a multiple sclerosis drug may be used to block HIV infection and reduce the latent reservoir.
Alejandro Villagra, PhD, assistant professor of biochemistry and molecular medicine, and his research team published a new study in Cancer Research, finding the genetic modifier HDAC6 controls tumor growth and halts metastasis in triple-negative breast cancer in vivo.
Juan Reyes, MD, and Shant Ayanian, MD, both assistant professors of medicine, published research in the journal Future Medicine, finding five biomarkers associated with higher odds of clinical deterioration and death in COVID-19 patients.
Two PhD students at SMHS recently earned predoctoral fellowship awards from the National Institutes of Health.